Gastric Cancer - No Longer Enrolling clinical trials at UCSF
1 in progress, 1 open to new patients
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
open to eligible people ages 18 years and up
This is a three-part, open-label, safety, tolerability, and PK study of FPA144. Patients will be enrolled in Part 1 (A or B, dose escalation) or Part 2 (dose expansion) of the study, but not both.
San Francisco, California and other locations